Literature DB >> 9059852

Vasodilator effects of C-type natriuretic peptide on cerebral arterioles in rats.

Y Mori1, M Takayasu, Y Suzuki, M Shibuya, J Yoshida, H Hidaka.   

Abstract

The vasodilator effects of C-type natriuretic peptide (CNP) were investigated in isolated rat cerebral arterioles. CNP caused dose-dependent vasodilation, maximally by 10.0 +/- 2.2% at 10(-6) M. The median effective concentration (EC50) was 5.2 x 10(-10) M. In contrast, atrial natriuretic peptide and B-type natriuretic peptide, other members of the natriuretic peptide family, produced little or no vasodilation. Pretreatment with methylene blue (10(-4) M) abolished CNP-induced vasodilation, whereas pretreatment with NG-monomethyl-L-arginine or indomethacin did not inhibit vasodilation. Thus, CNP is suggested to cause significant vasodilation in cerebral arterioles via a cyclic guanosine monophosphate-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059852     DOI: 10.1016/s0014-2999(96)00991-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  C-type natriuretic peptide concentrations in the plasma and cerebrospinal fluid of patients with subarachnoid hemorrhage.

Authors:  K Ikeda; T Ikeda; T Onizuka; H Terashi; T Fukuda
Journal:  Crit Care       Date:  2000-12-22       Impact factor: 9.097

Review 2.  The Interplay between cGMP and Calcium Signaling in Alzheimer's Disease.

Authors:  Aileen Jehle; Olga Garaschuk
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

Review 3.  Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis?

Authors:  Tudor M Griffith
Journal:  Br J Pharmacol       Date:  2004-03       Impact factor: 8.739

Review 4.  C-type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature.

Authors:  Amie J Moyes; Adrian J Hobbs
Journal:  Int J Mol Sci       Date:  2019-05-08       Impact factor: 5.923

5.  C-type natriuretic peptide preserves central neurological function by maintaining blood-brain barrier integrity.

Authors:  Cristina Perez-Ternero; Patrick N Pallier; Jordi L Tremoleda; Alessio Delogu; Cathy Fernandes; Adina T Michael-Titus; Adrian J Hobbs
Journal:  Front Mol Neurosci       Date:  2022-10-04       Impact factor: 6.261

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.